<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2658-6533</journal-id><journal-title-group><journal-title>Research Results in Biomedicine</journal-title></journal-title-group><issn pub-type="epub">2658-6533</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.18413/2313-8955-2019-5-1-0-7</article-id><article-id pub-id-type="publisher-id">1611</article-id><article-categories><subj-group subj-group-type="heading"><subject>Medicine (miscellaneous)</subject></subj-group></article-categories><title-group><article-title>Signal molecules involved in the formation of new nerve endings in endometriosis (review)</article-title><trans-title-group xml:lang="en"><trans-title>Signal molecules involved in the formation of new nerve endings in endometriosis (review)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Andreev</surname><given-names>Alexander E.</given-names></name><name xml:lang="en"><surname>Andreev</surname><given-names>Alexander E.</given-names></name></name-alternatives><email>alexander_597@mail.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Kleimenova</surname><given-names>Tatyana S.</given-names></name><name xml:lang="en"><surname>Kleimenova</surname><given-names>Tatyana S.</given-names></name></name-alternatives></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Drobintseva</surname><given-names>Anna O.</given-names></name><name xml:lang="en"><surname>Drobintseva</surname><given-names>Anna O.</given-names></name></name-alternatives></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Polyakova</surname><given-names>Victoriya O.</given-names></name><name xml:lang="en"><surname>Polyakova</surname><given-names>Victoriya O.</given-names></name></name-alternatives><email>vopol@yandex.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Kvetnoy</surname><given-names>Igor M.</given-names></name><name xml:lang="en"><surname>Kvetnoy</surname><given-names>Igor M.</given-names></name></name-alternatives></contrib></contrib-group><pub-date pub-type="epub"><year>2019</year></pub-date><volume>5</volume><issue>1</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/medicine/2019/1/Биомедицинские_иссл-95-108.pdf" /><abstract xml:lang="ru"><p>Background: The mechanism of the development of pain syndrome in endometriosis is heterogeneous. The study has been established that in the recently formed endometriotic implants there are neoneurogenesis processes, which consist in the formation of small sensory fibers with increased sensory sensitivity. This results in an increased pain sensitivity of patients, which, together with inflammatory processes, can lead to the development of chronic pelvic pain. The aim of the study: To collect and structure information regarding molecular markers directly or indirectly involved in the NGF signaling cascade. Materials and methods: The review includes modern data of foreign and domestic articles on this topic found in Pubmed. Results: This review examines the molecular mechanisms of work in healthy patients and in the pathology of the nerve growth factor, the androgen receptor, ARID1A, and peripherin. These molecular markers are involved in the signal transmission through the molecular cascade, which indicates the formation of new neurons, followed by the development of pain syndrome in endometriosis. Conclusion: In the review, there are still insufficiently studied markers, whose study is of interest for studying this issue. The information obtained should promote a better understanding of neo-neuronal processes in endometriosis to improve the diagnosis of this disease and to treat chronic pelvic pain.</p></abstract><trans-abstract xml:lang="en"><p>Background: The mechanism of the development of pain syndrome in endometriosis is heterogeneous. The study has been established that in the recently formed endometriotic implants there are neoneurogenesis processes, which consist in the formation of small sensory fibers with increased sensory sensitivity. This results in an increased pain sensitivity of patients, which, together with inflammatory processes, can lead to the development of chronic pelvic pain. The aim of the study: To collect and structure information regarding molecular markers directly or indirectly involved in the NGF signaling cascade. Materials and methods: The review includes modern data of foreign and domestic articles on this topic found in Pubmed. Results: This review examines the molecular mechanisms of work in healthy patients and in the pathology of the nerve growth factor, the androgen receptor, ARID1A, and peripherin. These molecular markers are involved in the signal transmission through the molecular cascade, which indicates the formation of new neurons, followed by the development of pain syndrome in endometriosis. Conclusion: In the review, there are still insufficiently studied markers, whose study is of interest for studying this issue. The information obtained should promote a better understanding of neo-neuronal processes in endometriosis to improve the diagnosis of this disease and to treat chronic pelvic pain.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>nerve growth factor</kwd><kwd>androgen receptor</kwd><kwd>ARID1A</kwd><kwd>peripherin</kwd><kwd>endometriosis</kwd><kwd>chronic pelvic pain</kwd><kwd>neoneurogenesis</kwd></kwd-group><kwd-group xml:lang="en"><kwd>nerve growth factor</kwd><kwd>androgen receptor</kwd><kwd>ARID1A</kwd><kwd>peripherin</kwd><kwd>endometriosis</kwd><kwd>chronic pelvic pain</kwd><kwd>neoneurogenesis</kwd></kwd-group></article-meta></front><back><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Paltsev MA, Kvetnoy IM. [Neuroimmune-endocrinology of the endometrium]. In: [The guide to neuroimmune-endocrinology], 3rd ed. Moscow: ZAO &amp;ldquo;Shiko&amp;rdquo;; 2014:438-533. Russian.</mixed-citation></ref><ref id="B2"><mixed-citation>Yarmolinskaya MI, Aylamazyan EK. [Genital endometriosis. Different facets of the problem]. St. Petersburg: Eco-Vector; 2017. Russian.</mixed-citation></ref><ref id="B3"><mixed-citation>Kuznetsova IV. [Endometriosis and pelvic pain]. Effective pharmacotherapy. Obstetrics and gynecology. 2014;3(35):18-27. Russian.</mixed-citation></ref><ref id="B4"><mixed-citation>Cuevas M, Cruz ML, Ramirez AE, et al. Stress During Development of Experimental Endometriosis Influences Nerve Growth and Disease Progression. Reprod Sci. 2018;25(3):347-357. DOI: https://doi.org/10.1177/1933719117737846</mixed-citation></ref><ref id="B5"><mixed-citation>Kobayashi H, Yamada Y, Morioka S, et al. Mechanism of pain generation for endometriosis-associated pelvic pain. Archives of Gynecology and Obstetrics. 2014;289(1):13-21. DOI: https://doi.org/10.1007/s00404-013-3049-8</mixed-citation></ref><ref id="B6"><mixed-citation>Orellana R, Garc&amp;iacute;a-Solares J, Donnez J, et al. Important role of collective cell migration and nerve fiber density in the development of deep nodular endometriosis. Fertil Steril. 2017;107(4):987-995. DOI: https://doi.org/10.1016/j.fertnstert.2017.01.005</mixed-citation></ref><ref id="B7"><mixed-citation>Sheveleva TS, Bezhenar VF, Komlichenko EV, et al. Innovative approach in assessing the role of neurogenesis, angiogenesis and lymphangiogenesis in the pathogenesis of external genital endometriosis. Akusherstvo i ginekologiya Sankt-Peterburga. 2017;1:40-45. Russian.</mixed-citation></ref><ref id="B8"><mixed-citation>Wiesmann C, de Vos AM. Nerve growth factor: structure and function. Cell Mol Life Sci. 2001;58(5-6):748-59.</mixed-citation></ref><ref id="B9"><mixed-citation>Bucci C, Alifano P, Cogli L. The Role of Rab Proteins in Neuronal Cells and in the Trafficking of Neurotrophin Receptors. Membranes. 2014;4:642-677.</mixed-citation></ref><ref id="B10"><mixed-citation>Sun HL, Jiang T. The structure of nerve growth factor in complex with lysophosphatidylinositol. Acta Crystallogr F Struct Biol Commun. 2015;71(7):906-12. DOI: https://doi.org/10.1107/S2053230X15008870</mixed-citation></ref><ref id="B11"><mixed-citation>Bax B, Blundell TL, Murray-Rust J, et al. Structure of mouse 7S NGF: a complex of nerve growth factor with four binding proteins. Structure. 1997;5(10):1275-85. DOI: https://doi.org/10.1016/S0969-2126(97)00280-3</mixed-citation></ref><ref id="B12"><mixed-citation>Bradshaw RA, Murray-Rust J, Ib&amp;aacute;&amp;ntilde;ez CF, N et al. Nerve growth factor: structure/function relationships. Protein Sci. 1994;3(11):1901-13.</mixed-citation></ref><ref id="B13"><mixed-citation>Kryzhanovskii SA, Vititnova MB. Cardiovascular effects of the nerve growth factor: An analytical review. Part I: NGF-mediated intracellular signaling pathways. Human Physiology. 2011;37(2):217-228. DOI: https://doi.org/10.1134/S0362119711020113</mixed-citation></ref><ref id="B14"><mixed-citation>Kajitani T, Maruyama T, Asada H, et al. Possible involvement of nerve growth factor in dysmenorrhea and dyspareunia associated with endometriosis. Endocr J. 2013;60(10):1155-64. DOI: https://doi.org/10.1507/endocrj.EJ13-0027</mixed-citation></ref><ref id="B15"><mixed-citation>Peng B, Zhan H, Alotaibi F, et al. Nerve Growth Factor Is Associated With Sexual Pain in Women With Endometriosis. Reprod Sci. 2018;25(4):540-549. DOI: https://doi.org/10.1177/1933719117716778</mixed-citation></ref><ref id="B16"><mixed-citation>Dewanto A, Dudas J, Glueckert R, et al. Localization of TrkB and p75 receptors in peritoneal and deep infiltrating endometriosis: an immunohistochemical study. Reprod Biol Endocrinol. 2016;14(1):1-13. DOI: https://doi.org/10.1186/s12958-016-0178-5</mixed-citation></ref><ref id="B17"><mixed-citation>Streiter S, Fisch B, Sabbah B, et al. The importance of neuronal growth factors in the ovary. MHR: Basic science of reproductive medicine. 2016;22(1):3-17. DOI: https://doi.org/10.1093/molehr/gav057</mixed-citation></ref><ref id="B18"><mixed-citation>Scarpi D, Cirelli D, Matrone C, et al. Low molecular weight, non-peptidic agonists of TrkA receptor with NGF-mimetic activity. Cell Death Dis. 2012;3:1-13. DOI: https://doi.org/10.1038/cddis.2012.80</mixed-citation></ref><ref id="B19"><mixed-citation>Chen Y, Li D, Zhang Z, et al. Effect of siRNA against &amp;beta;-NGF on nerve fibers of a rat model with endometriosis. Reprod Sci. 2014;21(3):329-39. DOI: https://doi.org/10.1177/1933719113497279</mixed-citation></ref><ref id="B20"><mixed-citation>Kalinchenko SYu, Tyuzikov IА, Tishova YuА, et al. [The role of testosterone in the female body. Part 1. General and age-related endocrinology and physiology of testosterone in women]. DOKTOR.RU. 2015;14(115):59-64. Russian.</mixed-citation></ref><ref id="B21"><mixed-citation>Degtyar VT, Kushlinsky NE. [The specific properties of human androgen receptors]. Sibirskiy onkologicheskiy zhurnal. 2005;3(15):58-67. Russian.</mixed-citation></ref><ref id="B22"><mixed-citation>Aylamazyan EK. [Obstetrics]. 9th ed., corrected and expanded. Moscow: GEOTAR-Media; 2015. Russian.</mixed-citation></ref><ref id="B23"><mixed-citation>Castoria G, Auricchio F, Migliaccio A. Extranuclear partners of androgen receptor: at the crossroads of proliferation, migration, and neuritogenesis. FASEB J. 2017;31(4):1289-1300. DOI: https://doi.org/10.1096/fj.201601047R</mixed-citation></ref><ref id="B24"><mixed-citation>Fujimoto J, Hirose R, Sakaguchi H, et al. Expression of size-polymorphic androgen receptor (AR) gene in ovarian endometriosis according to the number of cytosine, adenine, and guanine (CAG) repeats in AR alleles. Steroids. 1999;64(8):526-9. DOI: https://doi.org/10.1016/S0039-128X(99)00025-2</mixed-citation></ref><ref id="B25"><mixed-citation>Grandi G, Mueller MD, Bersinger NA, et al. The association between progestins, nuclear receptors expression and inflammation in endometrial stromal cells from women with endometriosis. Gynecology Endocrinology. 2017;33(9):712-715. DOI: https://doi.org/10.1080/09513590.2017.1314458</mixed-citation></ref><ref id="B26"><mixed-citation>Simitsidellis I, Saunders PTK, Gibson DA. Androgens and endometrium: New insights and new targets. Molecular Cell Endocrinology. 2018;465(15):48-60. DOI: https://doi.org/10.1016/j.mce.2017.09.022</mixed-citation></ref><ref id="B27"><mixed-citation>Tamaya T, Motoyama T, Ohono Y, et al. Steroid receptor levels and histology of endometriosis and adenomyosis. Fertil Steril. 1979 Apr;31(4):396-400. DOI: https://doi.org/10.1016/S0015-0282 (16) 43935-X</mixed-citation></ref><ref id="B28"><mixed-citation>Shin JJ, Choi YM, Choi HY, et al. Androgen receptor cytosine, adenine, and guanine trinucleotide repeat polymorphism in Korean patients with endometriosis: A case-control study. Eur. J. Obstet. Gynecol. Reprod. Biol. 2017;218:1-4. DOI: https://doi.org/10.1016/j.ejogrb.2017.09.005</mixed-citation></ref><ref id="B29"><mixed-citation>Katiyar A, Sharma S, Singh TP, et al. Identification of Shared Molecular Signatures Indicate the Susceptibility of Endometriosis to Multiple Sclerosis. Front Genet. 2018;9:42. DOI: https://doi.org/10.3389/fgene.2018.00042</mixed-citation></ref><ref id="B30"><mixed-citation>Wang X, Haswell JR, Roberts CMW. Molecular Pathways: SWI/SNF (BAF) complexes are frequently mutated in cancer&amp;mdash;mechanisms and potential therapeutic insights. Clinical cancer research: an official journal of the American Association for Cancer Research. 2014;20(1):21-27.</mixed-citation></ref><ref id="B31"><mixed-citation>Wu JN, Roberts CWM. ARID1A Mutations in Cancer: Another Epigenetic Tumor Suppressor? Cancer discovery. 2013;3(1):35-43. DOI: 10.1158/2159-8290.CD-12-0361</mixed-citation></ref><ref id="B32"><mixed-citation>Helming KC, Wang X, Roberts CWM. Vulnerabilities of mutant SWI/SNF complexes in cancer. Cancer cell. 2014;26(3):309-317. DOI: https://doi.org/10.1016/j.ccr.2014.07.018</mixed-citation></ref><ref id="B33"><mixed-citation>Wu RC, Wang TL, Shih IM. The emerging roles of ARID1A in tumor suppression. Cancer Biology &amp;amp; Therapy. 2014;15(6):655-664. DOI: https://doi.org/10.4161/cbt.28411</mixed-citation></ref><ref id="B34"><mixed-citation>Anglesio MS, Papadopoulos N, Ayhan A, et al. Cancer-Associated Mutations in Endometriosis without Cancer. The New England journal of medicine. 2017;376(19):1835-1848. DOI: 10.1056/NEJMoa1614814</mixed-citation></ref><ref id="B35"><mixed-citation>Winarto H, Tan MI, Sadikin M, et al. ARID1A Expression is Down-Regulated by Oxidative Stress in Endometriosis and Endometriosis-Associated Ovarian Cancer. Translational Oncogenomics. 2017;9:1-7. DOI: 10.1177 / 1177272716689818</mixed-citation></ref><ref id="B36"><mixed-citation>Borrelli GM, Abr&amp;atilde;o MS, Taube ET, et al. Loss of BAF250a (ARID1A) in rectovaginal deep-infiltrating endometriosis, endometriomas and involved pelvic sentinel lymph nodes. MHR: Basic science of reproductive medicine. 2016;22(5):329-337. DOI: https://doi.org/10.1093/molehr/gaw009</mixed-citation></ref><ref id="B37"><mixed-citation>Mao T-L, Shih I-M. The roles of ARID1A in gynecologic cancer. Journal of Gynecologic Oncology. 2013;24(4):376-381. DOI: https://doi.org/10.3802/jgo.2013.24.4.376&amp;nbsp;</mixed-citation></ref><ref id="B38"><mixed-citation>Takeda T, Banno K, Okawa R, et al. ARID1A gene mutation in ovarian and endometrial cancers. Oncology Reports. 2016;35(2):607-613. DOI: https://doi.org/10.3892/or.2015.4421</mixed-citation></ref><ref id="B39"><mixed-citation>Samartzis EP, Noske A, Dedes KJ et al. ARID1A Mutations and PI3K/AKT Pathway Alterations in Endometriosis and Endometriosis-Associated Ovarian Carcinomas. International Journal of Molecular Sciences. 2013;14(9):18824-18849. DOI: 10.3390/ijms140918824</mixed-citation></ref><ref id="B40"><mixed-citation>Hol EM, Capetanaki Y. Type III Intermediate Filaments Desmin, Glial Fibrillary Acidic Protein (GFAP), Vimentin, and Peripherin. Cold Spring Harb Perspect Biol. 2017;9(12):1-18.</mixed-citation></ref><ref id="B41"><mixed-citation>Zhao J, Liem RKH. &amp;alpha;-Internexin and Peripherin: Expression, Assembly, Functions, and Roles in Disease. Methods Enzymol. 2016;568:477-507. DOI: https://doi.org/10.1016/bs.mie.2015.09.012</mixed-citation></ref><ref id="B42"><mixed-citation>Portier MM, Escurat M, Landon F, et al. Peripherin and neurofilaments: expression and role during neural development. C R Acad Sci III. 1993 Sep;316(9):1124-40.</mixed-citation></ref><ref id="B43"><mixed-citation>Greaves E, Horne AW, Jerina H, et al. EP2 receptor antagonism reduces peripheral and central hyperalgesia in a preclinical mouse model of endometriosis. Scientific Reports. 2017;7:1-10. DOI: https://doi.org/10.1038/srep44169</mixed-citation></ref><ref id="B44"><mixed-citation>Eyster KM, Klinkova O, Kennedy V, et al. Whole genome deoxyribonucleic acid microarray analysis of gene expression in ectopic versus eutopic endometrium. Fertil Steril. 2007 Dec;88(6):1505-33. DOI: https://doi.org/10.1016/j.fertnstert.2007.01.056</mixed-citation></ref><ref id="B45"><mixed-citation>Sassone J, Taiana M, Lombardi R, et al. ALS mouse model SOD1G93A displays early pathology of sensory small fibers associated to accumulation of a neurotoxic splice variant of peripherin. Human Molecular Genetics. 2016;25(8):1588-1599. DOI: https://doi.org/10.1093/hmg/ddw035</mixed-citation></ref></ref-list></back></article>